Isoniazid inhibits the metabolism of several drugs, resulting in clinically
significant interactions in some patients, Clinical trials and case report
s have documented that isoniazid can cause increased phenytoin and carbamaz
epine serum concentrations and toxicity, In relatively high doses, isoniazi
d can also cause increased effect of theophylline and warfarin, Isoniazid i
nhibits metabolism of selected benzodiazepines and vitamin D. Inhibition of
monoamine oxidase and histaminase by isoniazid can cause significant drug-
food interactions, Food greatly decreases isoniazid bioavailability, Althou
gh probably best recognized as an inhibitor of drug metabolism, isoniazid h
as a biphasic effect of inhibition-induction on one cytochrome P450 isozyme
, CYP2E1, which partially explains the interaction with acetaminophen and i
ncreased risk of hepatotoxicity, Continued investigations will likely resul
t in discovery of new isoniazid interactions.